Boston Scientific Corporation BSX recently announced the receipt of the FDA’s approval for its WaveWriter Alpha portfolio of Spinal Cord Stimulator (“SCS”) Systems. The U.S. commercial launch of the ...
MARLBOROUGH, Mass., Jan. 14, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) has announced a limited market release of the WaveWriter Alpha™ portfolio of Spinal Cord Stimulator (SCS) systems. The ...
Boston Scientific, a global medical technology company, announced the European launch of the WaveWriter Alpha portfolio of Spinal Cord Stimulator (SCS) Systems. The portfolio, consisting of four MRI ...
Boston Scientific is releasing in the United States its Wavewriter Alpha line of spinal cord stimulators. The four Wavewriter Alpha pain management devices provide Bluetooth connectivity, allow ...
Marlborough medical device manufacturer Boston Scientific Corp. has announced a limited market release of a new pain-relief system that uses electrical impulses in the spine to block pain signals. The ...
MARLBOROUGH, Mass., Sept. 30, 2020 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced the European launch of the WaveWriter Alpha™ portfolio of Spinal Cord Stimulator (SCS) Systems. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback